Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by TechCrunch, Rebecca Bellan, Kirsten Korosec, Anthony Ha, Max Zeff, and Theresa Loconsolo. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TechCrunch, Rebecca Bellan, Kirsten Korosec, Anthony Ha, Max Zeff, and Theresa Loconsolo or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

How Chipiron's rethinking the future of MRI

30:29
 
Share
 

Manage episode 508305130 series 3419174
Content provided by TechCrunch, Rebecca Bellan, Kirsten Korosec, Anthony Ha, Max Zeff, and Theresa Loconsolo. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TechCrunch, Rebecca Bellan, Kirsten Korosec, Anthony Ha, Max Zeff, and Theresa Loconsolo or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Medical device funding is hitting levels we haven't seen since 2021, with investors pouring billions into diagnostics and imaging companies. But while innovation has raced ahead, a fundamental problem still hasn't changed: critical medical hardware like MRI machines cost millions of dollars and are gatekept by large hospitals. So how do you take one of the most expensive, hospital-bound technologies and make it available anywhere?

Evan Kervella, founder and CEO of Paris-based startup Chipiron, joined Equity to walk us through the problem and his vision for solving it.

Listen to the full episode to hear about:

  • The unscalable nature of traditional MRI machines that rely on superconducting magnets and liquid helium.

  • How Chipiron is building installation ease and patient experience into its scaling mission.

  • Why Chipiron’s lightweight MRI technology isn’t designed to compete with old school machines.

  • Longevity movement backers.

  • Why it’s okay to chase M&A as an exit strategy, especially in the medical industry.

Equity will be back Friday with our weekly news roundup, so stay tuned.

Equity is TechCrunch’s flagship podcast, produced by Theresa Loconsolo, and posts every Wednesday and Friday.

Subscribe to us on Apple Podcasts, Overcast, Spotify and all the casts. You also can follow Equity on X and Threads, at @EquityPod.

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

686 episodes

Artwork
iconShare
 
Manage episode 508305130 series 3419174
Content provided by TechCrunch, Rebecca Bellan, Kirsten Korosec, Anthony Ha, Max Zeff, and Theresa Loconsolo. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TechCrunch, Rebecca Bellan, Kirsten Korosec, Anthony Ha, Max Zeff, and Theresa Loconsolo or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Medical device funding is hitting levels we haven't seen since 2021, with investors pouring billions into diagnostics and imaging companies. But while innovation has raced ahead, a fundamental problem still hasn't changed: critical medical hardware like MRI machines cost millions of dollars and are gatekept by large hospitals. So how do you take one of the most expensive, hospital-bound technologies and make it available anywhere?

Evan Kervella, founder and CEO of Paris-based startup Chipiron, joined Equity to walk us through the problem and his vision for solving it.

Listen to the full episode to hear about:

  • The unscalable nature of traditional MRI machines that rely on superconducting magnets and liquid helium.

  • How Chipiron is building installation ease and patient experience into its scaling mission.

  • Why Chipiron’s lightweight MRI technology isn’t designed to compete with old school machines.

  • Longevity movement backers.

  • Why it’s okay to chase M&A as an exit strategy, especially in the medical industry.

Equity will be back Friday with our weekly news roundup, so stay tuned.

Equity is TechCrunch’s flagship podcast, produced by Theresa Loconsolo, and posts every Wednesday and Friday.

Subscribe to us on Apple Podcasts, Overcast, Spotify and all the casts. You also can follow Equity on X and Threads, at @EquityPod.

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

686 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play